One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for weight loss, and major food conglomerates are trying to cater to their ...
A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...